Capstone Therapeutics Corp. is a biotechnology company. It develops a pipeline of novel therapeutic peptides and other molecules aimed at helping patients with under-served medical conditions. The company was founded in July 1987 and is headquartered in Tempe, AZ.
Company profile
Ticker
CAPS
Exchange
Website
CEO
Jock M. Holliman
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Orthologic Corp, Orthologic Corporation
SEC CIK
Corporate docs
IRS number
860585310
Latest filings (excl ownership)
15-12G
Securities registration termination
25 Sep 19
SC 13E3/A
Going private transaction (amended)
9 Sep 19
8-K
Entry into a Material Definitive Agreement
26 Aug 19
10-Q
2019 Q2
Quarterly report
13 Aug 19
DEF 14A
Definitive proxy
10 Jul 19
SC 13E3/A
Going private transaction (amended)
3 Jul 19
PRER14A
Preliminary revised proxy
3 Jul 19
CORRESP
Correspondence with SEC
3 Jul 19
UPLOAD
Letter from SEC
28 Jun 19
SC 13E3
Going private transaction
31 May 19
Latest ownership filings
SC 13D/A
Capstone Therapeutics Corp.
20 Aug 19
SC 13D/A
Capstone Therapeutics Corp.
19 Mar 19
SC 13G/A
Capstone Therapeutics Corp.
13 Feb 19
SC 13G
Capstone Therapeutics Corp.
11 Feb 19
3
Initial statement of insider ownership
4 Feb 19
4
NEIL S SUBIN
28 Dec 18
SC 13D/A
Capstone Therapeutics Corp.
20 Nov 18
SC 13D/A
Capstone Therapeutics Corp.
18 May 18
SC 13D/A
Capstone Therapeutics Corp.
1 Feb 18
4
Matthew E. Lipman
1 Feb 18
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|